FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dexrazoxane Injection
Status: Discontinuation
»Therapeutic Categories: Oncology; Pediatric

Expand all

Pfizer Pharmaceuticals (New 01/14/2021)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
250 mg Single Dose Vial (NDC 00013-8717-62) 01/14/2021 Discontinuation of the manufacture of the drug
500 mg Single Dose Vial (NDC 00013-8717-62) 01/14/2021 Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English